Pulliam Kasiemobi E, Pritts Timothy A
Department of Surgery, University of Cincinnati, 231 Albert Sabin Way, Mail Location 0558, Cincinnati, Ohio 45267-0558.
Curr Geriatr Rep. 2019 Sep;8(3):153-159. doi: 10.1007/s13670-019-00287-5. Epub 2019 Jun 13.
The first description of non-invasive ventilation use began in the 1920s. Since then, its role in patient care has evolved through increased clinical knowledge and scientific advancements. The utilization of non-invasive ventilation has broadened from initial application in acute in-hospital ICU settings to now include the outpatient settings. This review discusses the history of non-invasive ventilation and its role in acute in-hospital chronic obstructive pulmonary disease (COPD) exacerbations, cardiogenic pulmonary edema, and weaning from mechanical ventilation in the elderly. The elderly population represents a significant portion of patients hospitalized for the aforementioned conditions. These groups often have more limitations related to the use of invasive mechanical ventilation (IMV), therefore, it is essential to understand the impact of non-invasive ventilation on hospital outcomes.
There is strong clinical evidence supporting the use of non-invasive ventilation in patients with respiratory failure secondary to acute COPD exacerbations and cardiogenic pulmonary edema. When compared to standard medical management of these conditions, there is a consistent and significant reduction in the rate of endotracheal intubation and in-hospital mortality.
The basis of noninvasive ventilation applicability has been determined by significant reduction in mortality and intubation rates. Although survival benefits have been observed, there still remain limitations to the clinical applicability of non-invasive ventilation in certain patient populations and conditions that require further investigation.
无创通气的首次应用描述始于20世纪20年代。从那时起,随着临床知识的增加和科学的进步,其在患者护理中的作用不断演变。无创通气的应用范围已从最初在医院急性重症监护病房(ICU)的应用扩展到现在包括门诊环境。本综述讨论无创通气的历史及其在医院内急性慢性阻塞性肺疾病(COPD)加重、心源性肺水肿以及老年患者机械通气撤机中的作用。老年人群体占因上述疾病住院患者的很大一部分。这些人群在使用有创机械通气(IMV)方面往往有更多限制,因此,了解无创通气对医院结局的影响至关重要。
有强有力的临床证据支持在急性COPD加重和心源性肺水肿继发呼吸衰竭的患者中使用无创通气。与这些疾病的标准药物治疗相比,气管插管率和院内死亡率持续显著降低。
无创通气适用性的基础已由死亡率和插管率的显著降低所确定。尽管已观察到生存益处,但在某些患者群体和情况下,无创通气的临床适用性仍存在局限性,需要进一步研究。